Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Global Flow Cytometry Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts

Published

on

Dublin, Jan. 20, 2023 (GLOBE NEWSWIRE) — The “Flow Cytometry Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering.

The global flow cytometry market size reached US$ 4.9 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 8.0 Billion by 2027, exhibiting a CAGR of 8.51% during 2021-2027.

Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Flow cytometry refers to a biophysical and laser-based analytical technology that is used in the analysis of the cells or micelles that are usually suspended in a fluid using a laser beam.

This technique aids in subclassifying cell types and detecting residual levels of disease through probes to develop the best treatment plan for the patient. Fluorescent probes, such as bisoxonol, can bind to proteins present on the cell membrane to facilitate the identification of various stages of cell injuries or necrosis.

This technique also aids in understanding the structure and composition of the cells for chromosome analysis, cancer diagnosis, protein expression and diagnosis of diseases and hematological malignancies.

The increasing prevalence of chronic medical ailments, such as HIV-AIDS and cancer, is one of the key factors driving the growth of the market. The diagnosis of these diseases requires toxicity testing and an accurate, rapid and sensitive prognosis technique, which, in turn, is creating a positive outlook for the market growth.

Furthermore, the widespread adoption of stem cell therapy is also enhancing the utilization of flow cytometry. Rising awareness regarding the benefits of this technique in immunophenotyping, cell sorting, cell proliferation assays and intracellular calcium flux is acting as another major growth-inducing factor.

Additionally, several technological advancements, such as the integration of flow cytometry devices with artificial intelligence (AI) platforms, along with the advent of advanced methods, are also contributing to the market growth. Other factors, including improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biotechnology, are projected to drive the market further.

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Apogee Flow Systems Ltd., BD (Becton, Dickinson and Company), Beckman Coulter Inc. (Danaher Corporation), Bio-RAD Laboratories Inc., Enzo Life Sciences Inc., Luminex Corporation, Merck KGaA, Sony Biotechnology Inc., Sysmex Partec GmbH, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report
1. What was the size of the global flow cytometry market in 2021?
2. What is the expected growth rate of the global flow cytometry market during 2022-2027?
3. What are the key factors driving the global flow cytometry market?
4. What has been the impact of COVID-19 on the global flow cytometry market?
5. What is the breakup of the global flow cytometry market based on the product and service?
6. What is the breakup of the global flow cytometry market based on the technology?
7. What is the breakup of the global flow cytometry market based on the application?
8. What is the breakup of the global flow cytometry market based on the end-user?
9. What are the key regions in the global flow cytometry market?
10. Who are the key players/companies in the global flow cytometry market?

Report Attribute Details
No. of Pages 147
Forecast Period 2021 – 2027
Estimated Market Value (USD) in 2021 $4.9 Billion
Forecasted Market Value (USD) by 2027 $8 Billion
Compound Annual Growth Rate 8.5%
Regions Covered Global

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Flow Cytometry Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product and Service
6.1 Instruments
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Reagents and Consumables
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Accessories
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Software
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Services
6.5.1 Market Trends
6.5.2 Market Forecast

7 Market Breakup by Technology
7.1 Cell-Based Flow Cytometry
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Bead-Based Flow Cytometry
7.2.1 Market Trends
7.2.2 Market Forecast

8 Market Breakup by Application
8.1 Oncology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Drug Discovery
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Disease Diagnosis
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Stem Cell Therapy
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Organ Transplantation
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Hematology
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Others
8.7.1 Market Trends
8.7.2 Market Forecast

9 Market Breakup by End-User
9.1 Hospitals and Clinics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Academic and Research Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Agilent Technologies Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Apogee Flow Systems Ltd.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 BD (Becton, Dickinson and Company)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Beckman Coulter Inc. (Danaher Corporation)
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Bio-RAD Laboratories Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Enzo Life Sciences Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Luminex Corporation
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Merck KGaA
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Sony Biotechnology Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Sysmex Partec GmbH
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.11 Thermo Fisher Scientific Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/kz0h41

Attachment


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

University medical centers in Germany choose Sectra’s radiology solution to streamline workflows and shorten lead times for patients

Published

on

university-medical-centers-in-germany-choose-sectra’s-radiology-solution-to-streamline-workflows-and-shorten-lead-times-for-patients

LINKÖPING, Sweden, April 23, 2024 /PRNewswire/ — International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed two contracts to provide the radiology module of its enterprise imaging solution with two university medical centers in Germany—Universitätsklinikum Tübingen and Universitätsmedizin Göttingen. By implementing Sectra’s radiology solution, the hospitals aim to improve and streamline radiology workflows with Sectra’s tools for enhanced reporting efficiency, in turn speeding up diagnostics.

“When choosing a vendor, we wanted one that could provide us with a stable and fast system. We also wanted one facilitating collaboration among our radiologists. That way we can streamline our radiology workflows and in turn shorten lead times for patients as well as reduce the ever increasing workload for radiologists,” says Dr. Babak Panahi, Managing Senior Physician and Head of CT and CT Intervention, Universitätsmedizin Göttingen.
Universitätsmedizin Göttingen and Universitätsklinikum Tübingen are two university medical centers located in the cities of Göttingen and Tübingen in Germany managing 300,000 and 600,000 radiology exams a year. The two separate contracts for Sectra’s radiology solution were both signed during the third quarter of Sectra’s 2023/2024 fiscal year.
“Radiologists are under a lot of pressure as they are challenged to handle more images and more complex cases with less resources. Having a solution designed to streamline radiology workflows, facilitating reading and reporting of images, is therefore paramount. I am happy and excited to support Universitätsmedizin Göttingen and Universitätsklinikum Tübingen on their journey towards efficient radiology diagnostics,” says Guido Bötticher, Managing Director, Sectra DACH.
The radiology module is part of Sectra’s enterprise imaging solution that provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Visit Sectra’s website to read more about Sectra and why it’s top-ranked in ‘Best in KLAS’.
About SectraSectra contributes to a healthier and safer society by assisting health systems throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. The company, founded in 1978, is headquartered in Linköping, Sweden, with direct sales in 19 countries, and distribution partners worldwide. Sales in the 2022/2023 fiscal year totaled SEK 2,351 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit Sectra’s website.
For further information, please contact: Dr. Torbjörn Kronander, CEO and President Sectra  AB, 46 (0) 705 23 52 27Marie Ekström Trägårdh, Executive Vice President Sectra AB and President Sectra Imaging IT Solutions, 46 (0)708 23 56 10
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/sectra/r/university-medical-centers-in-germany-choose-sectra-s-radiology-solution-to-streamline-workflows-and,c3965089
The following files are available for download:
https://news.cision.com/sectra/i/sectra-s-radiology-solution,c3291783
Sectra’s radiology solution
 

View original content:https://www.prnewswire.co.uk/news-releases/university-medical-centers-in-germany-choose-sectras-radiology-solution-to-streamline-workflows-and-shorten-lead-times-for-patients-302124211.html

Continue Reading

Artificial Intelligence

New CPS Protection Platform: TXOne Networks Unveils SageOne at GISec Global

Published

on

new-cps-protection-platform:-txone-networks-unveils-sageone-at-gisec-global

TAIPEI, April 23, 2024 /PRNewswire/ — TXOne Networks, a frontrunner in the realm of cyber-physical systems (CPS) security, is set to unveil its groundbreaking CPS security platform, SageOne, at the highly anticipated GISec Global from April 23rd to 25th, 2024. Attendees can find TXOne Networks showcasing SageOne at stand B99 in hall 5. This innovative platform consolidates all CPS security products onto a single, central management platform, promising streamlined operations and optimized threat detection capabilities.

SageOne, aptly named “Wise Man Number One,” serves as a comprehensive management console providing a holistic view of the CPS attack surface within operational technology (OT) environments. By enabling centralized control of TXOne’s three core product lines – Stellar for endpoint protection, Element for security inspection, and Edge for network defense – SageOne facilitates integrated OT security throughout the lifecycle of protected assets, ensuring robust threat detection and response mechanisms.
Key features of SageOne include:
CPS Attack Surface Management: Prioritizing operational security by offering clear visibility into the overall security posture of OT environments, SageOne identifies security focal points, illuminating asset information and security controls.Integrated Lifecycle Protection: Through centralized management, SageOne simplifies cybersecurity governance and fosters collaborative defense. It serves as an abstraction layer, facilitating contextualization and consolidation of data across multiple products, offering tailored, task-oriented consoles for executives, security personnel, and plant leaders.CPS Threat Detection & Response: SageOne aggregates security insights from various solutions to scout for potential risks, enabling early caution and response to both known and unknown threats.SageOne’s foundation rests upon advanced components, including Threat Intelligence, Behavior-Based AI Analytics Engines, Compliance Framework, Data Visualizer, and Ecosystem Integrator, ensuring comprehensive protection and seamless integration of different tools and technologies.
With its focus on analyzing unexpected behavior and unknown threats, SageOne enables the identification of suspicious events through cross-telemetry analysis within the OT-native XDR engine. This amalgamation of advanced technologies and user-friendly interface ensures the protection of critical infrastructures.
For rapid threat response, SageOne issues early warnings of suspicious behavior and orchestrates cross-telemetry analysis for CPS Threat Detection & Response. Integrated Lifecycle Protection ensures the security of devices and systems throughout their service life, contributing to great cost efficiency.
TXOne Networks reaffirms its commitment to CPS security and continuous advancement in OT security through SageOne. Visit TXOne Networks at the GISec Global from April 23rd to 25th, 2024, at stand B99 in hall 5.
For further updates and information, follow TXOne Networks on the blog, Twitter, and LinkedIn.
About TXOne Networks:
TXOne Networks provides OT security products ensuring reliability and security in industrial control systems and operational technology environments through the OT Zero Trust methodology. Collaborating with leading industrial manufacturers and critical infrastructure operators, TXOne Networks offers practical and business-friendly approaches to OT defense. Its network and endpoint-based products secure OT networks and mission-critical devices in real-time with high security depth.
Website: www.txone.com 
Photo – https://mma.prnewswire.com/media/2389611/SageOne_header_3.jpg

View original content:https://www.prnewswire.co.uk/news-releases/new-cps-protection-platform-txone-networks-unveils-sageone-at-gisec-global-302119386.html

Continue Reading

Artificial Intelligence

Imparta Launches World’s First Sales Methodology-Aware AI

Published

on

imparta-launches-world’s-first-sales-methodology-aware-ai

LONDON, April 23, 2024 /PRNewswire/ — Imparta Ltd, a global leader in performance improvement for customer-facing teams, has announced the release of i-Coach AI, the world’s first sales methodology-aware AI.

Over the past 18 months, AI has reshaped many industries and professions, with sales being no exception. Yet, generic LLMs such as ChatGPT are poor at coaching, and at selling. Even data-driven AI insights are only as good as the qualitative frameworks that underpin their observations.
i-Coach AI is the first expert Sales AI Coach that follows a proven, structured coaching process, and is fluent in all aspects of sales, account management, negotiation, customer success, commercial and business acumen, sales management and sales leadership. It is powered by Imparta’s award-winning, research-based Agile 3D methodology and complete, modular skills library.
Richard Barkey, Founder and CEO of Imparta, said “GenAI is one of the few truly transformative technologies in our lifetimes, and one that no sales organisation can ignore. We are genuinely excited to introduce i-Coach AI, an enterprise-grade coaching tool for salespeople, managers and leaders. I’m not exaggerating when I say that I’m using i-Coach AI myself, to think through strategies around specific clients, and indeed for the whole business. This tool is designed to integrate seamlessly across various sales ecosystems and tech stacks, and provides targeted, IP-aware coaching and practice simulations of customer conversations, at multiple points of need.”
As part of the launch, Imparta will host a webinar on April 23rd and May 2nd, hosted by Richard Barkey, titled ‘Leveraging Sales Methodology-Aware AI at Scale in the Enterprise’. Click here to learn more.
During this webinar, Richard will announce details of i-Coach AI and Imparta’s upcoming course for sales teams: Leveraging AI for Sales. He will also set out a range of essential use cases that we are rolling out across Imparta’s agile sales ecosystem and across the tech stack.
About Imparta
Imparta is a global leader in performance improvement for Sales, CX and Leadership. Our modular ecosystem includes three elements, developed through 25 years of research and experience with leading global organisations: Agile Sales Methodology, Agile Change Process and AI Sales Technology.
Whether you need to plug a gap in your existing training, provide self-paced learning, or build an entire Sales, CX or Leadership Academy, get in touch at [email protected].
Website: www.imparta.com
Photo: https://mma.prnewswire.com/media/2392278/i_Coach_Imparta_Ltd.jpg
Contact details: Adam [email protected] Tel: +44 (0) 20 7610 8800

View original content:https://www.prnewswire.co.uk/news-releases/imparta-launches-worlds-first-sales-methodology-aware-ai-302123771.html

Continue Reading

Trending